刘永振实验室

Liu Y#, Liu H#, Hu Z#, Ding Y#, Pan XB, Zou J, Xi J, Yu G, Huang H, Luo MT, Guo F, Liu S, Sheng Q, Jia J, Zheng YT, Wang J, Chen X*, Guo JT*, Wei L*, Lu F*. HBV virions produced under nucleos(t)ide analogue treatment are mainly not infectious due to irreversible DNA chain termination. Hepatology. 2020 Feb; 71(2):463-476.

Liu Y#, Zeng W, Xi J, Liu H, Liao H, Yu G, Chen X, Lu F*. Over-gap PCR amplification to identify presence of replication-competent HBV DNA from integrated HBV DNA: an updated occult HBV infection definition. Journal of Hepatology. 2019 Mar; 70(3):557.

Liu Y#, Cafiero TR, Park D, Biswas A, Winer BY, Cho CH, Bram Y, Chandar V, O’ Connell AK, Gertje HP, Crossland N, Schwartz RE, Ploss A*. Targeted viral adaptation generates a simian-tropic hepatitis B virus that infects marmoset cells. Nature Communications. 2023 Jun; 14(1):3582.

Liu Y#, Park D, Cafiero TR, Bram Y, Chandar V, Tseng A, Gertje HP, Crossland RA, Su L, Schwartz RE, Ploss A*. Molecular clones of genetically distinct hepatitis B virus genotypes reveal distinct host and drug treatment responses. JHEP Reports. 2022 Sep; 4(9):100535. 

Liu Y#, Maya S, Carver S, O’Connell A.K., Zen A, Gertje H.P., Crossland N., Ploss A*. Development of a dual channel detection system for pan-genotypic simultaneous quantification of hepatitis B and delta viruses. Emerging Microbes & Infections. 2024 April; (13): 2350167. 

Wang Y#, Liu Y#*, Zhang T#, Guan G, Mao T, Liu H, Zhang J, Lu F*, Chen X*. LncCDCA3L inhibits cell proliferation via a novel RNA structure-based crosstalk with CDCA3 in hepatocellular carcinoma. Liver International. 2022 Mar; 42(6):1432-1446. (Co-first author, Co-corresponding author)

Liu Y#, Qi X#, Zeng Z, Wang Lu, Wang J, Zhang T, Xu Q, Shen C, Zhou G, Yang S, Chen X*, Lu F. CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice. Scientific Reports. 2017 Jun; 7(1):2796

Liu Y#, Zhang J, Liu H, Guan G, Zhang T, Wang L, Qi X, Chen CC, Liu J, Chao D, Lu F, Chen X. Compensatory Upregulation of Aldo-Keto Reductase 1B10 to Protect Hepatocytes Against Oxidative Stress During Hepatocarcinogenesis. American Journal of Cancer Research. 2019 Dec; 9(12):2730-2748.

Liu Y#, Maya S#, Ploss A. Animal Models of Hepatitis B Virus Infection-Success, Challenges, and Future Directions. Viruses. 2021 Apr; 13(5):777.

Wang J, Huang H, Liu Y, Chen R, Yan Y, Shi S, Xi J, Zou J, Yu G, Feng X, Lu F. HBV Genome and Life Cycle. Advances in Experimental Medicine and Biology. 2020; 1179:17-37